Pfizer Inc. issued a voluntary nationwide recall Wednesday for two lots of Relpax (eletriptan hydrobromide) 40-milligram tablets due to the potential contamination. The lots are AR5407 and CD4565.

Read more here.

Subscribe To Our Weekly Newsletter

Subscribe To Our Weekly Newsletter

Get a weekly digest of our posts straight to your inbox! We promise, no spam ever.

You have Successfully Subscribed!

Pin It on Pinterest

Share This